Health Care Financing and Economics, VA Boston Healthcare System, Boston, MA; Department of Psychiatry, Boston University School of Medicine, Boston, MA; Health Policy and Management, Boston University School of Public Health, Boston, MA; Leonard Davis Institute, University of Pennsylvania, Philadelphia, PA.
Health Serv Res. 2013 Dec;48(6 Pt 1):1996-2013. doi: 10.1111/1475-6773.12076. Epub 2013 Jun 26.
To investigate how integration between Medicare Advantage plans and health care providers is related to plan premiums and quality ratings.
We used public data from the Centers for Medicare and Medicaid Services (CMS) and the Area Resource File and private data from one large insurer. Premiums and quality ratings are from 2009 CMS administrative files and some control variables are historical.
We estimated ordinary least-squares models for premiums and plan quality ratings, with state fixed effects and firm random effects. The key independent variable was an indicator of plan-provider integration.
With the exception of Medigap premium data, all data were publicly available. We ascertained plan-provider integration through examination of plans' websites and governance documents.
We found that integrated plan-providers charge higher premiums, controlling for quality. Such plans also have higher quality ratings. We found no evidence that integration is associated with more generous benefits.
Current policy encourages plan-provider integration, although potential effects on health insurance products and markets are uncertain. Policy makers and regulators may want to closely monitor changes in premiums and quality after integration and consider whether quality improvement (if any) justifies premium increases (if they occur).
研究医疗保险优势计划与医疗服务提供者之间的整合程度与计划保费和质量评级之间的关系。
我们使用了医疗保险和医疗补助服务中心(CMS)和区域资源文件的公共数据,以及一家大型保险公司的私人数据。保费和质量评级来自 2009 年 CMS 管理文件,部分控制变量是历史数据。
我们使用状态固定效应和公司随机效应,对保费和计划质量评级进行了普通最小二乘法模型估计。关键的自变量是计划提供者整合的指标。
除了补充医疗保险保费数据外,所有数据均公开可用。我们通过检查计划的网站和治理文件来确定计划提供者的整合情况。
我们发现,在控制质量的情况下,整合计划提供者的保费更高。这些计划的质量评级也更高。我们没有发现整合与更慷慨的福利之间存在关联的证据。
现行政策鼓励计划提供者整合,尽管其对医疗保险产品和市场的潜在影响尚不确定。政策制定者和监管机构可能希望在整合后密切监测保费和质量的变化,并考虑质量改进(如果有的话)是否证明保费上涨是合理的(如果发生的话)。